San Diego, CA, United States of America

Christopher Ronald Smith

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 91(Granted Patents)


Location History:

  • Sandwich, GB (2005)
  • San Diego, CA (US) (2007 - 2024)

Company Filing History:


Years Active: 2005-2025

where 'Filed Patents' based on already Granted Patents

27 patents (USPTO):

Title: Christopher Ronald Smith: A Pioneer in pan-KRas Inhibitor Research

Introduction

Christopher Ronald Smith is an influential inventor based in San Diego, California. With an impressive portfolio comprising 24 patents, Smith has significantly contributed to the field of pharmaceutical development, particularly in cancer treatment.

Latest Patents

Among Smith's notable innovations are his recent patents focusing on Tetrahydropyridopyrimidine pan-KRas inhibitors. These compounds aim to inhibit several KRas mutations, including KRas wild type, KRas G12A, KRas G12C, KRas G12D, KRas G12R, KRas G12S, KRas G12V, KRas G13D, and KRas Q61H. The patents detail pharmaceutical compositions that incorporate these compounds along with methods for their application. Another significant patent involves KRas G12D inhibitors, which specifically target the activity of KRas G12D, contributing to cancer treatment innovations.

Career Highlights

Christopher Ronald Smith has held key positions in leading pharmaceutical companies, including Mirati Therapeutics, Inc. and Takeda Pharmaceutical Company Limited. His expertise and research have positioned him as a critical figure in the pharmaceutical industry, particularly in cancer therapy development.

Collaborations

Throughout his career, Smith has collaborated with esteemed colleagues such as John David Lawson and Matthew Arnold Marx. Together, they have advanced research initiatives that have led to groundbreaking discoveries and inventions in their field.

Conclusion

Christopher Ronald Smith's commitment to innovation and his unparalleled contributions to pan-KRas inhibitor research highlight his significance in the pharmaceutical industry. His ongoing work continues to pave the way for new treatments and therapies, showcasing the impact of dedicated inventors in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…